Trade Acurx Pharmaceuticals, Inc. - ACXP CFD

Add to favourite

0.68

1.49%

View detailed chart

To be able to trade stocks like this, create an account and apply for a stock listing.

Create Account

Summary
Historical Data

Trading сonditions

Spread

0.05

Long position overnight fee

-0.02354%

Short position overnight fee

0.001318%

Overnight fee time

22:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	0.67
Open	0.65
1-Year Change	-78.96%
Day's Range	0.65 - 0.69

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Feb 28, 2025	0.68	0.03	4.62%	0.65	0.69	0.65
Feb 27, 2025	0.67	-0.01	-1.47%	0.68	0.69	0.65
Feb 26, 2025	0.69	-0.01	-1.43%	0.70	0.72	0.68
Feb 25, 2025	0.70	-0.10	-12.50%	0.80	0.81	0.69
Feb 24, 2025	0.82	0.08	10.81%	0.74	0.82	0.66
Feb 21, 2025	0.75	0.05	7.14%	0.70	0.80	0.69
Feb 20, 2025	0.65	-0.04	-5.80%	0.69	0.69	0.64
Feb 19, 2025	0.68	-0.01	-1.45%	0.69	0.70	0.68
Feb 18, 2025	0.72	0.00	0.00%	0.72	0.73	0.71
Feb 14, 2025	0.72	0.00	0.00%	0.72	0.74	0.70
Feb 13, 2025	0.73	0.01	1.39%	0.72	0.74	0.71
Feb 12, 2025	0.72	0.00	0.00%	0.72	0.73	0.71
Feb 11, 2025	0.72	-0.02	-2.70%	0.74	0.74	0.71
Feb 10, 2025	0.74	-0.02	-2.63%	0.76	0.76	0.73
Feb 7, 2025	0.75	0.00	0.00%	0.75	0.76	0.74
Feb 6, 2025	0.76	0.01	1.33%	0.75	0.77	0.74
Feb 5, 2025	0.78	0.03	4.00%	0.75	0.79	0.74
Feb 4, 2025	0.75	0.05	7.14%	0.70	0.75	0.70
Feb 3, 2025	0.71	0.00	0.00%	0.71	0.72	0.70
Jan 31, 2025	0.71	-0.01	-1.39%	0.72	0.73	0.70

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, LLC, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. The company was founded in 2017 and is based in Staten Island, New York.

Industry:

Biotechnology & Medical Research (NEC)

259 Liberty Avenue
STATEN ISLAND
NEW YORK 10305
US

News

USD forecast - third party data round up

The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.

10:02, 27 February 2025

Microsoft Stock Price Forecast for 2025 and beyond: Third party price target

We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...

18:29, 7 February 2025

Ripple XRP price prediction: Third-party price target

Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com

15:29, 6 February 2025

Apple Store on Fifth Avenue, New York, October 2016

Apple (AAPL) stock price forecast: third-party price target

We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.

11:22, 6 February 2025